About Kritika Sarmah
Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist.
She earned her bachelor's degree in commerce and is currently pursuing the CFA program.
With her fundamental approach, she aims to help investors identify untapped investment opportunities.
Recent Articles By Kritika Sarmah
Is Bristol-Myers a Good Dividend Stock to Pick up Right Now?
Leading pharma company Bristol-Myers Squibb’s (BMY) fiscal year 2022 revenue and EPS were in line with analysts’ estimates. While BMY continues to advance its innovative portfolio and pipeline, is it a good dividend stock to pick up right now? Read more to find out...
1 Hot Tech Stock to Buy Before the End of February
Leading networking company Nokia (NOK) announced robust growth in the fiscal year 2022. Moreover, the company looks confident in its near-term performance. And given bullish analysts’ expectations, NOK might be worth buying this month. Read more...
4 Pharma Stocks to Buy Now for the Long Haul
The pharma industry has experienced tremendous growth in recent years. The industry should continue to grow, driven by the growing market for personalized medicine and e-pharmacies. Hence, pharma stocks Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and Zoetis (ZTS) might be worth buying for the long term. Also, these companies pay stable dividends. Read on...
3 Stocks You Won't Have Regrets About Buying in 2023
January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH) might be ideal investments amid market uncertainties in 2023. Moreover, these companies pay reliable dividends. Read more...
3 Agriculture Stocks to Feed Your Portfolio in 2023 And 1 to Sell
The rapid adoption of innovative technologies and growing sustainability and vertical farming initiatives should boost the global agriculture market. Hence, fundamentally strong agricultural stocks Archer-Daniels-Midland (ADM), Nutrien (NTR), and Dole (DOLE) could be ideal buys now. However, considering the macro headwinds, fundamentally weak Cronos Group (CRON) might be best avoided. Read more...
The 3 Best Industrial Stocks to Buy Now
Despite macroeconomic headwinds, total industrial production rose in January. Moreover, robust government investments and technological advancements are boosting the sector’s prospects. Hence, quality industrial stocks General Electric (GE), Watts Water Technologies (WTS), and Core Molding Technologies (CMT) might be ideal buys. Read more...
3 Cruise Line Stocks to Sell Short or Avoid Completely in 2023
Sticky inflation and looming recessionary fears might keep the cruise line industry under pressure this year. Hence, fundamentally weak cruise line stocks Royal Caribbean Cruises (RCL), Carnival (CCL), and Norwegian Cruise Line (NCLH) might be best sold short or completely avoided in 2023. Read more...
3 Must-Buy Nasdaq Stocks for 2023
Consumers showing resiliency in the face of rising inflation have helped the U.S. GDP to come in better than expected in the last quarter. Moreover, hopes of the economy avoiding a deep recession this year are rising. The Nasdaq Composite began this year on a positive note. Hence, fundamentally strong Nasdaq stocks Cisco Systems (CSCO), Cintas (CTAS), and Coca-Cola Consolidated (COKE) might be solid buys. Keep reading...
1 Entertainment Stock to Own in 2023 and 2 to Sell if You Haven’t Already
The entertainment industry has been under pressure due to macroeconomic headwinds. Moreover, the industry is struggling amid the ad recession, which is marring growth. However, the industry’s long-term prospects look bright as it is evolving with new technologies. While we think fundamentally strong entertainment stock AMC Networks (AMCX) might be worth buying, Walt Disney (DIS) and Warner Bros. (WBD) could be best avoided now. Read on...